Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have noticed it too
2% Down the Day after a 60% Run up is strong! It could close Green!
In time, if the plan is executed correctly, there is no reason PACV couldn't go much higher.
PACV is working its way up the Breakout Board this morning.
Today is the day when all is revealed. IMO
Good morning Arizonminingman, and all you other SnoBar Heads,
Maybe its just E-Trade, because I get this message:
"This price type you specified is not allowed for orders on OTC, Bulletin Board, Pink Sheet, non-equity, and certain other securities. Please consider entering a limit order."
Good Luck today!
You can't place a Market order on a penny stock in OTC. Has to be Limit
I have suspected for some time that with the way this has been trading, there is someone buying in, and it could likely be part of this Acquisition.
It must be a done deal!
Doesn't PACV also own the means of production?
Looking at Eddie's history, he is the one that is really driving this bus. Holding my shares!
SnoBar is her baby, and her baby is growing up to be a Beauty.
She wouldn't never sell it off at this point. IMO
She is moving up on the Breakout Board!
Thanks for the Info pb!
What we know is PACV has an outstanding product that may have secured a national distribution contract. We also know they have secured the production ability already. This adds up to me and why I bought in. Any bank will loan on a secured contract.
I expect we may see 1 more small dump, as I saw 4 million get pulled from the Ask yesterday. I do not see them using the RS option with this size OS, but they may. IMO
Green tomorrow
Its time for next move up!
"Frozen Cocktails Market: Key Players Manchester Drinks Co ltd. Harvest Hill Beverage Company Cocktail Natives Kold Cocktails Four Blue Palms, Inc. Snobar Cocktails Arbor Mist Winery The Ico Co N1CE Company Ltd. The Absolut Company."
https://newsvarsity.com/2019/09/15/frozen-cocktails-market-a-comprehensive-assessment-of-current-dynamics-and-emerging-avenues/
Im glad you liked it, the video along with others are on the west coast Website
Here is Shannon, yes she is a doll!
Show me the Medic Money Jenny!
Delcath is listed as a player in this also.
How many applications can their system be used for???
https://honestbusinessman24.com/2019/04/bile-duct-cancer-treatment-market-economic-conditions-acquisitions-mergers-developments-and-forecast/
Looking good DCTH
Lets see some filings now
Congrats to whoever bought the past few days.
Patience wins here, when the time comes.
Chill!
I posted this back in May 2018.
The wheels turn very slowly!
"You don't do this without the world taking interest!
The GGPO’s update was based on its evaluation of published data on treatment with CHEMOSAT as a loco-regional treatment for melanoma liver metastases. Following this evaluation, and after soliciting additional feedback from the oncology community in Germany, treatment with CHEMOSAT was classified with Evidence Level 1B, indicating the second highest level of evidence. Treatment with CHEMOSAT is the sole therapy classified with this top designation. Other loco-regional therapies previously included in the guidelines have been designated with Evidence Level 4, indicating an absence of clinical trial supporting evidence"
Now this is getting interesting. It's good to see some of the vets show back up.
A lot of good could happen here, Lord knows we paid our dues!
Looks promising, buying the dip tomorrow.
I didn't realize Medac is a Global Company in over 90 countries. Doesn't the signed agreement just cover Europe?
Weren't the warrents before the reverse split?
Kaufmaga,
From what I remember from past releases, Hepatic Infusion has been accepted in Germany as the main treatment for cancer metastasized in the Liver. As more countries recognize its results, I don't see why it wouldn't be in high demand world wide for that matter.
This Optimistic view cost me a lot here, I want to see more progression than just this last agreement.
Why aren't case results from Europe publicized?
I look forward to their next quarterly report.
Hello Kaufmaga, I have owned shares, and lost a lot in the past 2 years if that qualifies for old timer. I see a lot of positive here. We know they are capable of generating $6 million per year just in Europe, without FDA approval. I don't know why this business model cannot be applied throughout the world, even in US with "Right to Try". Only management, or a fumble in the FDA Red Zone can scrog it now. So it seems!
This unexpected agreement with the Germans is a great development. Enough for me to take a position again. What I am anticipating is the possibility of an even better deal being signed with their Asian affiliates. One that I assume Jenny is already ironing out.
Any input would be appreciated
Insider Buy www.mareainformativa.com/2018/11/23/william-dodge-rueckert-buys-6500-shares-of-delcath-systems-inc-dcth-stock-updated-updated.html
You don't do this without the world taking interest!
The GGPO’s update was based on its evaluation of published data on treatment with CHEMOSAT as a loco-regional treatment for melanoma liver metastases. Following this evaluation, and after soliciting additional feedback from the oncology community in Germany, treatment with CHEMOSAT was classified with Evidence Level 1B, indicating the second highest level of evidence. Treatment with CHEMOSAT is the sole therapy classified with this top designation. Other loco-regional therapies previously included in the guidelines have been designated with Evidence Level 4, indicating an absence of clinical trial supporting evidence.
Not overly confident, more like cautiously optimistic.
Glad you brought that up Lwe, first let me say your idea that the CEO is just a crook and doesn't care is pretty far fetched to say the least.
I have lost more money here than I care to admit, but that's my fault, no one else's.
Secondly, consider what would happen to market cap if we do start to see insider buying.
Good luck to all
IMO, The PR campaign is working to stabilize share price. I expect more PR followed by NASDAQ listing before any offering. Jenny is building the case, then will have a much better pool for funding with listing. Common sense!
But anything is possible in Del lala land.
“The DSMB’s continued recommendation to proceed without modification with the FOCUS Trial as planned confirms once again our own observations of the safety profile of PHP therapy based on prior research and our commercial experience with CHEMOSAT in Europe,” said Jennifer K. Simpson, Ph.D., MSN, CRNP President and CEO of Delcath. “Given that safety concerns with the previous generation product and procedure were the primary issue in the FDA’s previous assessment, we are pleased with the safety profile demonstrated by our therapy in the trial thus far.”
From May 3rd press release
Not pumping, but it is possible Jenny is pulling this off sooner than expected